Safety, tolerability and pharmacokinetics of the phosphodiesterase 2 inhibitor BI 474121: An overview of phase I randomized trials in healthy volunteers
BI 474121 demonstrated favourable safety and pharmacokinetic profiles in healthy Caucasian and Japanese individuals, supporting further clinical development.
Authors
- Andreas Scholz
- Rainer-Georg Goeldner
- Jennifer Schaible
- Norio Yamamura
Institutions
- Boehringer Ingelheim (Germany) (DE)
- Boehringer Ingelheim (Japan) (JP)
Publication Details
- Journal
- Journal of Psychopharmacology
- Published
- 2024-09-01
- DOI
- https://doi.org/10.1177/02698811241273814
- Citations
- 1
- Primary Topic
- Phosphodiesterase function and regulation
- Type
- article
- Field-Weighted Citation Impact
- 0.23